Sponsored content By Evaluate There are plenty of questions about what 2025 might hold for the pharmaceutical market. While uncertainty driven by factors like the Inflation Reduction Act (IRA) have been in play for some time, new questions are being raised almost daily with an incoming Trump administration, the BIOSECURE Act, and an ever-changing geopolitical […]
